[ESPR] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
08-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- 245.54%
YoY- 289.42%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 18,836 7,978 1,840 145,419 0 0 0 -
PBT -56,731 -90,935 -78,249 87,379 -46,130 -40,541 -14,585 25.39%
Tax 13,742 8,139 4,539 0 0 482 457 76.29%
NP -70,473 -90,935 -78,249 87,379 -46,130 -40,541 -14,585 30.00%
Tax Rate - - - 0.00% - - - -
Total Cost 89,309 98,913 80,089 58,040 46,130 40,541 14,585 35.23%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin -374.14 -1,139.82 -4,252.66 60.09 0.00 0.00 0.00 -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -1.16 -3.50 -2.84 3.26 -1.73 -1.80 -0.65 10.12%
EPS Diluted -1.16 -3.50 -2.84 3.07 -1.73 -1.80 -0.65 10.12%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.